tradingkey.logo

Cryoport Inc

CYRX
9.690USD
+0.190+2.00%
終値 11/25, 16:00ET15分遅れの株価
485.17M時価総額
8.14直近12ヶ月PER

Cryoport Inc

9.690
+0.190+2.00%

詳細情報 Cryoport Inc 企業名

Cryoport, Inc. is engaged in supply chain solutions for cell and gene therapies. The Company’s supply chain solutions enable manufacturers, contract manufacturers (CDMO’s), contract research organizations (CRO’s), developers, and researchers to carry out their business with certainty. The Company provides a broad array of supply chain solutions for the life sciences industry. Through its platform of critical products and solutions, including advanced temperature-controlled packaging, informatics, specialized bio-logistics services, bio-storage, bio-services, and cryogenic systems, the Company is enabling the future of medicine worldwide, through its systems, compliant procedures, and approach to supply chain management. Its products and services include Cryoport Express Shippers, Cryoport ELITE Shipper Systems, Cryoport Consulting Services, Cryoport Bioservices, CRYOGENE, CRYOPDP Temperature-controlled Logistics, Cryoport Cryoshuttle, IntegriCell Services, Tec4Med, and others.

Cryoport Incの企業情報

企業コードCYRX
会社名Cryoport Inc
上場日Jul 24, 2015
最高経営責任者「CEO」Mr. Jerrell Wilson (Jerry) Shelton
従業員数1090
証券種類Ordinary Share
決算期末Jul 24
本社所在地112 Westwood Place, Suite 350
都市BRENTWOOD
証券取引所NASDAQ Capital Market Consolidated
United States of America
郵便番号37027
電話番号19492321900
ウェブサイトhttps://www.cryoport.com/
企業コードCYRX
上場日Jul 24, 2015
最高経営責任者「CEO」Mr. Jerrell Wilson (Jerry) Shelton

Cryoport Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Jerrell Wilson (Jerry) Shelton
Mr. Jerrell Wilson (Jerry) Shelton
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.00M
+2.56%
Mr. Daniel M. (Dan) Hancock
Mr. Daniel M. (Dan) Hancock
Independent Director
Independent Director
45.86K
+102.52%
Ms. Linda Baddour
Ms. Linda Baddour
Independent Director
Independent Director
44.90K
+107.03%
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Independent Director
Independent Director
38.43K
+186.15%
Mr. Mark Sawicki
Mr. Mark Sawicki
Senior Vice President, Chief Scientific Officer
Senior Vice President, Chief Scientific Officer
--
--
Dr. Ramkumar Mandalam, Ph.D.
Dr. Ramkumar Mandalam, Ph.D.
Independent Director
Independent Director
--
--
Mr. Robert S. Stefanovich
Mr. Robert S. Stefanovich
Chief Financial Officer, Senior Vice President, Chief Administrative Officer
Chief Financial Officer, Senior Vice President, Chief Administrative Officer
--
--
Mr. Ram M. Jagannath
Mr. Ram M. Jagannath
Independent Director
Independent Director
--
--
Mr. Scott Eckstein
Mr. Scott Eckstein
Investor Relations
Investor Relations
--
--
Mr. Edward J. Zecchini
Mr. Edward J. Zecchini
Senior Vice President, Chief Digital and Technology Officer
Senior Vice President, Chief Digital and Technology Officer
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Jerrell Wilson (Jerry) Shelton
Mr. Jerrell Wilson (Jerry) Shelton
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.00M
+2.56%
Mr. Daniel M. (Dan) Hancock
Mr. Daniel M. (Dan) Hancock
Independent Director
Independent Director
45.86K
+102.52%
Ms. Linda Baddour
Ms. Linda Baddour
Independent Director
Independent Director
44.90K
+107.03%
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Independent Director
Independent Director
38.43K
+186.15%
Mr. Mark Sawicki
Mr. Mark Sawicki
Senior Vice President, Chief Scientific Officer
Senior Vice President, Chief Scientific Officer
--
--
Dr. Ramkumar Mandalam, Ph.D.
Dr. Ramkumar Mandalam, Ph.D.
Independent Director
Independent Director
--
--

収益内訳

通貨: USD更新時刻: Mon, Oct 6
通貨: USD更新時刻: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
事業別USD
会社名
収益
比率
Life Science products
21.09M
46.39%
BioLogistics solutions
19.87M
43.72%
BioStorage/Bioservices
4.50M
9.89%
地域別USD
会社名
収益
比率
Americas
33.24M
73.12%
Asia Pacific
6.38M
14.04%
Europe & Middle East & Africa (EMEA)
5.83M
12.83%
事業別
地域別
事業別USD
会社名
収益
比率
Life Science products
21.09M
46.39%
BioLogistics solutions
19.87M
43.72%
BioStorage/Bioservices
4.50M
9.89%

株主

更新時刻: Mon, Nov 17
更新時刻: Mon, Nov 17
株主統計
種類
株主統計
株主統計
比率
Cadian Capital Management LP
9.95%
Morgan Stanley & Co. LLC
9.11%
BlackRock Institutional Trust Company, N.A.
6.74%
The Vanguard Group, Inc.
5.71%
Brown Capital Management, LLC
5.24%
他の
63.25%
株主統計
株主統計
比率
Cadian Capital Management LP
9.95%
Morgan Stanley & Co. LLC
9.11%
BlackRock Institutional Trust Company, N.A.
6.74%
The Vanguard Group, Inc.
5.71%
Brown Capital Management, LLC
5.24%
他の
63.25%
種類
株主統計
比率
Investment Advisor
42.52%
Investment Advisor/Hedge Fund
25.29%
Hedge Fund
22.33%
Research Firm
11.05%
Individual Investor
4.01%
Bank and Trust
0.67%
Sovereign Wealth Fund
0.43%
Pension Fund
0.42%
Family Office
0.10%

機関投資家保有株

更新時刻: Wed, Oct 1
更新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q3
368
48.89M
97.65%
-8.69M
2025Q2
394
50.37M
100.47%
-14.50M
2025Q1
409
50.98M
101.73%
-14.79M
2024Q4
407
51.87M
104.93%
-14.28M
2024Q3
422
52.00M
105.24%
-13.61M
2024Q2
423
53.55M
108.72%
-9.95M
2024Q1
437
55.31M
112.51%
-7.56M
2023Q4
468
54.03M
110.37%
-6.18M
2023Q3
482
49.41M
101.04%
-7.52M
2023Q2
492
49.81M
109.19%
-5.40M
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
Cadian Capital Management LP
4.97M
9.93%
-12.80K
-0.26%
Jun 30, 2025
Morgan Stanley & Co. LLC
4.55M
9.08%
-60.87K
-1.32%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
3.41M
6.8%
+151.66K
+4.66%
Jun 30, 2025
The Vanguard Group, Inc.
2.79M
5.57%
+43.03K
+1.57%
Jun 30, 2025
Brown Capital Management, LLC
3.80M
7.59%
-254.65K
-6.28%
Jun 30, 2025
Millennium Management LLC
2.56M
5.12%
+350.15K
+15.83%
Sep 24, 2025
Fred Alger Management, LLC
2.36M
4.71%
-173.42K
-6.85%
Jun 30, 2025
Thematics Asset Management SAS
1.66M
3.32%
+1.04M
+168.96%
Mar 31, 2025
Natixis Investment Managers SA
1.91M
3.82%
+216.94K
+12.78%
Jun 30, 2025
Assenagon Asset Management S.A.
1.50M
2.99%
+408.26K
+37.44%
Sep 30, 2025
詳細を見る

関連ETF

更新時刻: Thu, Nov 6
更新時刻: Thu, Nov 6
銘柄名
比率
Invesco NASDAQ Future Gen 200 ETF
0.52%
Inspire Small/Mid Cap ESG ETF
0.24%
JPMorgan Fundamental Data Science Small Core ETF
0.1%
Avantis US Small Cap Equity ETF
0.05%
Vanguard US Momentum Factor ETF
0.05%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.04%
Global X Russell 2000 ETF
0.02%
ProShares UltraPro Russell2000
0.02%
Invesco RAFI US 1500 Small-Mid ETF
0.02%
ProShares Hedge Replication ETF
0.02%
詳細を見る
Invesco NASDAQ Future Gen 200 ETF
比率0.52%
Inspire Small/Mid Cap ESG ETF
比率0.24%
JPMorgan Fundamental Data Science Small Core ETF
比率0.1%
Avantis US Small Cap Equity ETF
比率0.05%
Vanguard US Momentum Factor ETF
比率0.05%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
比率0.04%
Global X Russell 2000 ETF
比率0.02%
ProShares UltraPro Russell2000
比率0.02%
Invesco RAFI US 1500 Small-Mid ETF
比率0.02%
ProShares Hedge Replication ETF
比率0.02%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
種類
比率
データなし
日付
種類
比率
データなし

よくある質問

Cryoport Incの上位5名の株主は誰ですか?

Cryoport Incの上位5名の株主は以下のとおりです。
Cadian Capital Management LPは4.97M株を保有しており、これは全体の9.93%に相当します。
Morgan Stanley & Co. LLCは4.55M株を保有しており、これは全体の9.08%に相当します。
BlackRock Institutional Trust Company, N.A.は3.41M株を保有しており、これは全体の6.80%に相当します。
The Vanguard Group, Inc.は2.79M株を保有しており、これは全体の5.57%に相当します。
Brown Capital Management, LLCは3.80M株を保有しており、これは全体の7.59%に相当します。

Cryoport Incの株主タイプ上位3種は何ですか?

Cryoport Incの株主タイプ上位3種は、
Cadian Capital Management LP
Morgan Stanley & Co. LLC
BlackRock Institutional Trust Company, N.A.

Cryoport Inc(CYRX)の株式を保有している機関の数はいくつですか?

2025Q3時点で、Cryoport Incの株式を保有している機関は368社あり、保有株式の総市場価値は約48.89Mで、全体の97.65%を占めています。2025Q2と比較して、機関の持ち株は-2.82%増加しています。

Cryoport Incの最大の収益源は何ですか?

FY2025Q2において、Life Science products部門がCryoport Incにとって最大の収益を生み出しており、その金額は21.09Mで、全収益の46.39%を占めています。
KeyAI